Glenmark Pharmaceuticals Inc., USA

NJ · United States · Reporting entity ID 100000011170

Total reported 2019–2025

$2.05M

#1,023 of 2,960 reporting companies — 0% of all reported industry payments

$667 in general payments across 1 records, plus $2.05M in research funding across 1,686 records.

How it breaks down

General payments $667

Research funding $2,049,672

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.